Skip to content

Effects of Low-volume Aerobic Interval Training in Overweight Individuals at Increased Cardiometabolic Risk

Low-volume Aerobic Interval Training in Overweight Individuals at Increased Cardiometabolic Risk: Impact of Training Intensity on Cardiorespiratory Fitness, Cardiometabolic Risk Profile and Exercise Adherence

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03306069
Acronym
BELITA
Enrollment
154
Registered
2017-10-10
Start date
2017-11-01
Completion date
2020-04-15
Last updated
2020-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome, Overweight and Obesity

Keywords

Aerobic exercise, Interval training, VO2max, Health Promotion, Inflammation, Body Composition

Brief summary

The main purpose of this study is to compare the impact of aerobic interval training intensity on exercise adherence and changes in cardiorespiratory fitness, cardiometabolic risk profile, body composition, inflammatory markers and subjective health outcomes after a 12-week intervention trial in overweight individuals at increased cardiometabolic risk.

Interventions

OTHERControl

Individualized, weight-reducing nutritional therapy and counseling, during a study period of 12 weeks

OTHERHIIT

Procedures: Nutritional therapy (individualized, weightreducing nutritional therapy and counseling) during a study period of 12 weeks combined with supervised ergometer-based high-intensity interval training (HIIT). HIIT: * 2 sessions per week * 5x1 min at 80-95% HRmax * time-effort per week: \ 30 min

OTHERMIIT-HR

Procedures: Nutritional therapy (individualized, weightreducing nutritional therapy and counseling) during a study period of 12 weeks combined with supervised ergometer-based moderate-intensity interval training on the basis of HRmax (MIIT-HR). MIIT-HR: * 2 sessions per week * 5x1 min at 65-79% HRmax * time-effort per week: \ 30 min

OTHERMIIT-LT

Procedures: Nutritional therapy (individualized, weightreducing nutritional therapy and counseling) during a study period of 12 weeks combined with supervised ergometer-based moderate-intensity interval training on the basis of lactate threshold (MIIT-LT). MIIT-LT: * 2 sessions per week * session 1: 2x4 min / session 2: 5x1 min, each at 105% LT * time-effort per week: \ 30 min

Sponsors

University of Erlangen-Nürnberg Medical School
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Outcome Assessors involved in data analysis will not be aware of the arm to which the participants were allocated (single-blinded masking).

Intervention model description

Parallel Assignment parallel-group, randomized-controlled study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Body Mass Index \>/=30 * presence of at least 2 cardiometabolic risk factors

Exclusion criteria

* Healthy persons or patients under age * Overweight persons without any additional cardiometabolic risk factors * Pregnancy, Lactation * Psychological disorders, epilepsy, sever neurological disorders * Participation in other exercise- or nutrition studies within the last 6 months * acute cardiovascular disease * malignant disease * Electronic implants (defibrillator, pacemaker) * Persons in mental hospitals by order of authorities or jurisdiction

Design outcomes

Primary

MeasureTime frameDescription
Cardiorespiratory Fitness (CRF)12 weeks (baseline to 12 week follow-up assessment)CRF will be assessed by measuring Maximum Oxygen uptake (VO2max)

Secondary

MeasureTime frameDescription
Body Composition12 weeks (baseline to 12 week follow-up assessment)Muscle mass, fat mass and body water will be measured by Bioelectrical Impedance Analysis (BIA)
Insulin sensitivity12 weeks (baseline to 12 week follow-up assessment)Insulin sensitivity will be estimated using homeostasis model assessment index (HOMA)
Inflammation12 weeks (baseline to 12 week follow-up assessment)Inflammation will be assessed by measuring levels of inflammatory blood markers
Metabolic Syndrome Z-Score (MetS-Z-Score)12 weeks (baseline to 12 week follow-up assessment)MetS-Z-Score will be calculated from each individual's measures of waist circumference, mean arterial blood pressure, triglycerides, and HDL-cholesterol, based on equations specific to sex.
Pain scores12 weeks (baseline to 12 week follow-up assessment)Pain scores will be assessed by using the standardized and validated Chronic Pain Grade Questionnaire (CPGQ)
Perceived stress12 weeks (baseline to 12 week follow-up assessment)Perceived stress will be assessed by using the standardized and validated Perceived Stress Questionnaire (PSQ)
Subjective work ability12 weeks (baseline to 12 week follow-up assessment)Subjective work ability will be assessed by using the standardized and validated Work Ability Index Questionnaire (WAI)
Health-related quality of life12 weeks (baseline to 12 week follow-up assessment)Health-related quality of life will be assessed by using the standardized and validated EQ-5D-5L Questionnaire

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026